Acesis BioMed

Denver, United States

Acesis BioMed is a biomedical company that develops a platform of oral drug candidates for metabolic and endocrine disorders.

$1.3M raised

Jan 2023

Pre-Seed

Biotechnology Health Care Medical

Top Investors

KreaMedica

Founder Contacts

30,000+ verified contacts

Get Instant Access

Emails, phones & LinkedIn profiles

Frequently Asked Questions about Acesis BioMed

How much funding has Acesis BioMed raised?

Acesis BioMed has raised $1.3M in total funding. The most recent round was Pre-Seed. The last funding was announced in January 2023.

Who are Acesis BioMed's investors?

Acesis BioMed's investors include KreaMedica.

Where is Acesis BioMed headquartered?

Acesis BioMed is headquartered in Denver, United States.

What does Acesis BioMed do?

Acesis BioMed is a biomedical company that develops a platform of oral drug candidates for metabolic and endocrine disorders.

What stage is Acesis BioMed at?

Acesis BioMed is at the Pre-Seed stage.

Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated January 11, 2023.

MLA

"Acesis BioMed — Funding & Investors." VCBacked, January 11, 2023, https://www.vcbacked.co/company/acesis-biomed. Accessed July 4, 2026.

APA

VCBacked. (2023). Acesis BioMed — Funding & Investors. Retrieved July 4, 2026, from https://www.vcbacked.co/company/acesis-biomed

Wikipedia (cite web)

{{cite web |title=Acesis BioMed — Funding & Investors |url=https://www.vcbacked.co/company/acesis-biomed |website=VCBacked |access-date=July 4, 2026}}

Profile data sourced and verified per the VCBacked methodology. Last funding round dated January 11, 2023.

Similar Companies in Biotechnology

View all

Rapport Therapeutics

Boston$250.0M

Allterum Therapeutics

Houston$1.0M

AlpalifeBio

Woburn$9.8M

Renaissance BioScience

Vancouver$599K

Epsilogen

London$16.3M

Advanced Microbiome Interventions

Amsterdam$300K